SARCOMEDUSA Trademark

Trademark Overview

On Thursday, November 7, 2019, a trademark application was filed for SARCOMEDUSA with the United States Patent and Trademark Office. The USPTO has given the SARCOMEDUSA trademark a serial number of 88684179. The federal status of this trademark filing is REGISTERED as of Tuesday, February 2, 2021. This trademark is owned by SarcoMed USA. The SARCOMEDUSA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug discovery services
sarcomedusa

General Information

Serial Number88684179
Word MarkSARCOMEDUSA
Filing DateThursday, November 7, 2019
Status700 - REGISTERED
Status DateTuesday, February 2, 2021
Registration Number6262759
Registration DateTuesday, February 2, 2021
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 6, 2020

Trademark Statements

Description of MarkThe mark consists of the wording "SARCOMEDUSA" in stylized text.
Goods and ServicesDrug discovery services
Pseudo MarkSARCOMED USA; SARCOMED UNITED STATES OF AMERICA; SARCO MED USA

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 14, 2019
Primary Code042
First Use Anywhere DateMonday, June 1, 2020
First Use In Commerce DateMonday, June 1, 2020

Trademark Owner History

Party NameSarcoMed USA
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHouston, TX 77056
Party NameSarcoMed USA
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHouston, TX 77056
Party NameSarcoMed USA
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHouston, TX 77056

Trademark Events

Event DateEvent Description
Tuesday, February 2, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, December 30, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 29, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 10, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 1, 2020USE AMENDMENT FILED
Thursday, December 10, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 1, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, December 1, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 6, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 6, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, August 29, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 28, 2020EXAMINER'S AMENDMENT ENTERED
Friday, August 28, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, August 28, 2020EXAMINERS AMENDMENT E-MAILED
Friday, August 28, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, August 28, 2020EXAMINER'S AMENDMENT ENTERED
Friday, August 28, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, August 28, 2020EXAMINERS AMENDMENT E-MAILED
Friday, August 28, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, August 7, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 6, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 6, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 22, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 22, 2020NON-FINAL ACTION E-MAILED
Wednesday, July 22, 2020NON-FINAL ACTION WRITTEN
Thursday, June 25, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 24, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 12, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 12, 2020NON-FINAL ACTION E-MAILED
Wednesday, February 12, 2020NON-FINAL ACTION WRITTEN
Tuesday, February 11, 2020ASSIGNED TO EXAMINER
Thursday, November 14, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 11, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

sarcomedusa services discovery drug